透析服务市场 - 按类型（血液透析、腹膜透析）、按服务（急性透析、慢性透析）、最终用途（中心透析、居家透析）和预测，2024 - 2032 年

受慢性肾臟病 CKD 盛行率不断上升的推动，人口老化和生活方式相关疾病加剧了这一趋势，2024 年至 2032 年，全球透析服务市场的复合年增长率将超过 5.1%。根据美国国家糖尿病、消化和肾臟疾病研究所NIDDKD的最新资料，2021年，美国约有78.6万人被诊断出患有末期肾病ESRD，其中71%正在接受透析治疗。

随着慢性肾臟病发生率的上升，对透析服务的需求也随之激增。这种增长是由于患有终末期肾病 ESRD 和其他肾臟相关併发症的患者对维持生命治疗的需求所推动的。医疗保健系统在满足这一需求方面面临着越来越大的挑战，这促使透析技术和服务提供模式不断进步，以满足不断增长的需要定期和专业护理的患者群体。

整个透析服务市场根据类型、服务、最终用途和地区进行分类。

腹膜透析领域将在 2024 年至 2032 年间保持显着的复合年增长率。在全球健康挑战中，这种便利性尤其有吸引力。此外，技术的进步提高了腹膜透析的有效性和安全性，使其成为更多患者的可行选择。随着人们对其益处的认识不断增强，以及医疗保健系统寻求具有成本效益的解决方案，腹膜透析越来越被视为治疗慢性肾臟病的传统血液透析的更佳替代方案。

到 2032 年，急性透析领域将获得重要的透析服务市场份额。由于严重感染、手术和危重疾病引起的急性肾损伤 AKI 的发生率不断增加，急性透析领域正在不断增长。住院人数的不断增加以及重症监护病房对即时肾臟支持的需求正在推动对急性透析的需求。此外，急性透析技术的进步和患者治疗效果的改善正在鼓励医疗保健提供者更广泛地采用这些治疗方法。为了满足紧急医疗需求，急性透析领域正在经历显着成长。

由于慢性肾臟病 CKD 和糖尿病人口的迅速增加，到 2032 年，亚太地区透析服务市场将呈现显着的复合年增长率。经济发展和城市化正在导致生活方式的改变，从而增加了慢性肾臟病的危险因子。此外，改善的医疗基础设施和政府加强肾臟护理的措施使透析服务更容易获得。人们对肾臟健康的认识不断提高以及先进医疗技术的可用性正在激增这一需求。这些因素共同促进了亚太地区透析服务业的持续扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 末期肾病 (ESRD) 患者数量不断增加
    • 供肾短缺
    • 提高认识和教育
    • 糖尿病和高血压的发生率上升
  • 产业陷阱与挑战
    • 与透析相关的风险和併发症
    • 治疗费用高
• 成长潜力分析
• 监管环境
• 技术景观
• 未来市场趋势
• 报销场景
• 波特的分析
• PESTEL分析
• 缺口分析
• 价值链分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 血液透析
• 腹膜透析

第 6 章：市场估计与预测：按服务分类，2021 - 2032 年

• 主要趋势
• 急性透析
• 慢性透析

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 中心透析
• 居家透析

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Atlantic Dialysis Management Services, LLC
• Baxter International Inc.
• Centers for Dialysis Care
• DaVita Inc.
• Dialysis Clinic, Inc.
• Diaverum AB
• Fresenius Medical Care
• HATTIESBURG CLINIC
• Innovative Renal Care
• NephroPlus
• Northwest Kidney Centers
• Rogosin Institute
• Sanderling Renal Services
• Satellite Healthcare
• U.S. Renal Care, Inc.

Global Dialysis Services Market will witness over 5.1% CAGR from 2024 to 2032, driven by the escalating prevalence of chronic kidney diseases CKD, a trend amplified by aging populations and lifestyle-related illnesses. According to recent data from the National Institute of Diabetes and Digestive and Kidney Diseases NIDDKD, in 2021, about 786,000 individuals in the United States were diagnosed with End-Stage Renal Disease ESRD, with 71% undergoing dialysis treatment.

As CKD incidence rises, the demand for dialysis services surges correspondingly. This growth is propelled by the need for life-sustaining treatments among patients experiencing End-Stage Renal Disease ESRD and other kidney-related complications. Healthcare systems are increasingly challenged to meet this demand, prompting continuous advancements in dialysis technologies and service delivery models to cater to a growing patient population requiring regular and specialized care.

The overall dialysis services market is classified based on type, service, end-use, and region.

The peritoneal dialysis segment will maintain a notable CAGR between 2024 and 2032. The peritoneal dialysis sector offers patients more flexibility by allowing treatments to be performed at home, reducing the need for frequent hospital visits. This convenience is especially appealing amidst global health challenges. Additionally, advancements in technology have improved the effectiveness and safety of peritoneal dialysis, making it a viable option for more patients. As awareness grows about its benefits and as healthcare systems seek cost-effective solutions, peritoneal dialysis is increasingly viewed as a preferable alternative to traditional hemodialysis for managing chronic kidney disease.

By 2032, the acute dialysis segment will secure a significant dialysis services market share. The acute dialysis segment is rising due to the increasing incidence of acute kidney injuries AKI caused by severe infections, surgeries, and critical illnesses. The growing number of hospitalizations and the need for immediate renal support in intensive care units are driving the demand for acute dialysis. Additionally, advancements in acute dialysis techniques and improved patient outcomes are encouraging healthcare providers to adopt these treatments more widely. The acute dialysis segment is experiencing significant growth in response to urgent medical needs.

Asia Pacific dialysis services market will exhibit a significant CAGR through 2032 due to the rapid increase in the population with chronic kidney disease CKD and diabetes. Economic development and urbanization are contributing to lifestyle changes that heighten CKD risk factors. Additionally, improved healthcare infrastructure and government initiatives to enhance renal care make dialysis services more accessible. The rising awareness about kidney health and the availability of advanced medical technologies are catapulting the demand. These factors collectively contribute to the expanding dialysis services industry in Asia Pacific.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
    • 3.2.1.2 Shortage of donor kidneys
    • 3.2.1.3 Increasing awareness and education
    • 3.2.1.4 Rise in incidence of diabetes and hypertension
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Risks and complications associated with dialysis
    • 3.2.2.2 High treatment costs
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 GAP analysis
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hemodialysis
• 5.3 Peritoneal Dialysis

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Acute dialysis
• 6.3 Chronic dialysis

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 In-center dialysis
• 7.3 Home dialysis

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Atlantic Dialysis Management Services, LLC
• 9.2 Baxter International Inc.
• 9.3 Centers for Dialysis Care
• 9.4 DaVita Inc.
• 9.5 Dialysis Clinic, Inc.
• 9.6 Diaverum AB
• 9.7 Fresenius Medical Care
• 9.8 HATTIESBURG CLINIC
• 9.9 Innovative Renal Care
• 9.10 NephroPlus
• 9.11 Northwest Kidney Centers
• 9.12 Rogosin Institute
• 9.13 Sanderling Renal Services
• 9.14 Satellite Healthcare
• 9.15 U.S. Renal Care, Inc.